Women's Health

Test Code: 7137

CPT Code(s): 83001, 83002

Methodology: Immunoassay

Test Code: 8477

CPT Code(s): 82950

Methodology: Spectrophotometry (SP)

Clinical Significance: A value of 135 mg/dL or greater indicates the need for a full diagnostic, gestational glucose tolerance performed in the fasting state to determine if the patient has gestational diabetes.

Alternative Name(s): 1HR Gestational; 1HR Pregnancy Glucose; Gestational Glucose; Glucose OB; Gestational Glucose (1 Specimen); Glucose Gestational Screen; Glucose PG; Glucose 1RH 50gm Load

Test Code: 8396

CPT Code(s): 84702

Methodology: Immunoassay (IA)

Limitations: Heterophilic antibodies may produce low false-positive results; urinary hCG is negative if "phantom" hCG is suspected. Pituitary secretion may be a source of low level hCG in post menopausal women

Test Code: 91932

CPT Code(s): 87624

Includes: HPV Mrna e6/e7, Rectal

Methodology: Transcription-Mediated Amplification (TMA)

Clinical Significance: The HPV mRNA E6/E7 test is used in conjunction with cytology to evaluate anal dysplasia.

Alternative Name(s): Human Papillomavirus

Test Code: 20210

CPT Code(s): 80055, 85025, 86592, 86762, 86850, 86900, 86901, 87340

Includes:
CBC (includes Differential and Platelets)

Antibody Screen, RBC with Reflex to Identification, Titer, and Antigen Typing

ABO Group and Rh Type

RPR (Diagnosis) with Reflex to Titer and Confirmatory Testing

Hepatitis B Surface Antigen with Reflex Confirmation*

Rubella Virus IgG Antibody

Test Code: 6447

CPT Code(s): 86695, 86696

Methodology: Immunoassay (IA)

Test Code: 91476

CPT Code(s): 87996 (x2)

Includes: U. parvum DNA, U urealyticum DNA

Methodology: Real-Time Polymerase Chain Reaction (RT-PCR)

Clinical Significance: Ureaplasma spp has been associated with genital tract infection and infertility.

Alternative Names: None

BRCAvantage™ Plus (BRCA1, BRCA2, TP53, PTEN, CDH1, STK11, PALB2)

Test Code: 92587

CPT Code(s): 81162, 81405 (x2), 81479, 81321, 81323, 81406 (x2), 81404

Methodology: Exon Capture • Next Generation Sequencing • Multiplex Ligation-dependent Probe Amplification (MLPA)

BRCAvantage™ Comprehensive

Test Code: 91863

CPT Code(s): 81162

Supply: 193292 Lavender 4mL Blood Tube

Includes:
BRCA1 Sequencing, BRCA1 Deletion/Duplication, BRCA2 Sequencing, BRCA2 Deletion/Duplication, Comprehensive Interpretation

Methodology:
Next Generation Sequencing • Multiplex Ligation-dependent Probe Amplification (MLPA)

Reference Range(s): See Laboratory Report

Test Code: 11363

Includes: Chlamydia trachomatis, Neisseria gonorrhoeae

Methodology: Dual Kinetic Assay (DKA) • Target Capture • Transcription-Mediated Amplification (TMA)

Reference Range(s):
C.trachomatis RNA, TMA - Not detected
N.gonorrhoeae RNA, TMA - Not detected

This test was performed using the APTIMA^® COMBO2 Assay (GEN-PROBE).